X

Vous n'êtes pas connecté

Maroc Maroc - ZACKS.COM - All Stories - 23/Aug 16:00

Fabrinet (FN) Upgraded to Buy: Here's Why

Fabrinet (FN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Articles similaires

Sorry! Image not available at this time

Canon (CAJPY) Upgraded to Strong Buy: Here's Why

zacks.com - 29/Aug 16:00

Canon (CAJPY) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive...

Sorry! Image not available at this time

Zuora (ZUO) Upgraded to Strong Buy: Here's Why

zacks.com - 05/Sep 16:00

Zuora (ZUO) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive...

Sorry! Image not available at this time

American Tower (AMT) Upgraded to Buy: Here's Why

zacks.com - 05/Sep 16:00

American Tower (AMT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive...

Sorry! Image not available at this time

SmarFinancial (SMBK) Upgraded to Strong Buy: Here's Why

zacks.com - 06/Sep 16:00

SmarFinancial (SMBK) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might...

Sorry! Image not available at this time

SmarFinancial (SMBK) Upgraded to Strong Buy: Here's Why

zacks.com - 06/Sep 16:00

SmarFinancial (SMBK) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might...

Sorry! Image not available at this time

ARS Pharmaceuticals, Inc. (SPRY) Upgraded to Buy: Here's Why

zacks.com - 06/Sep 16:00

ARS Pharmaceuticals, Inc. (SPRY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This...

Sorry! Image not available at this time

ARS Pharmaceuticals, Inc. (SPRY) Upgraded to Buy: Here's Why

zacks.com - 06/Sep 16:00

ARS Pharmaceuticals, Inc. (SPRY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This...

Sorry! Image not available at this time

Chewy (CHWY) Upgraded to Buy: Here's Why

zacks.com - 04/Sep 16:00

Chewy (CHWY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the...

Sorry! Image not available at this time

Chewy (CHWY) Upgraded to Buy: Here's Why

zacks.com - 04/Sep 16:00

Chewy (CHWY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the...

Sorry! Image not available at this time

Mr Cooper (COOP) Upgraded to Strong Buy: Here's Why

zacks.com - 04/Sep 16:00

Mr Cooper (COOP) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might...